HP Halden Pharma and Adragos Pharma completed the acquisition of the plant of Fresenius Kabi.

HP Halden Pharma, a sterile pharmaceutical manufacturing facility, and Adragos Pharma, a contract development and manufacturing organization that offers a comprehensive range of services in the pharmaceutical industry. completed the acquisition of the plant of Fresenius Kabi, a healthcare company. Financial terms were not disclosed. “I’m pleased that we have been able to conclude this process and that the Prange Group will now be able to develop the plant and act on their credible and solid business plan,” Hans-Christian Meyer, Fresenius Kabi Head of Operations Management Pharma.